3-Bromo-8-phenylimidazo[1,2-c]pyrimidin-5(6H)-one

ID: ALA4743433

PubChem CID: 162647341

Max Phase: Preclinical

Molecular Formula: C12H8BrN3O

Molecular Weight: 290.12

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1[nH]cc(-c2ccccc2)c2ncc(Br)n12

Standard InChI:  InChI=1S/C12H8BrN3O/c13-10-7-14-11-9(6-15-12(17)16(10)11)8-4-2-1-3-5-8/h1-7H,(H,15,17)

Standard InChI Key:  RDZWIRNVBCHOTA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 17 19  0  0  0  0  0  0  0  0999 V2000
    1.2794  -12.0804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2794  -12.8976    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9847  -13.3021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6900  -12.8976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9847  -11.6677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6909  -12.0809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3021  -11.5371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9738  -10.7876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1596  -10.8684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5703  -11.6776    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3969  -13.3076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3923  -14.1244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0984  -14.5343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8079  -14.1271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8069  -13.3057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1002  -12.8995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6176  -10.2550    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  1  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  1 10  2  0
  4 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  9 17  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4743433

    ---

Associated Targets(Human)

CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLM-13 (2241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 290.12Molecular Weight (Monoisotopic): 288.9851AlogP: 2.45#Rotatable Bonds: 1
Polar Surface Area: 50.16Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.27CX Basic pKa: CX LogP: 1.98CX LogD: 1.98
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.75Np Likeness Score: -0.61

References

1. Jansa J,Jorda R,Škerlová J,Pachl P,Peřina M,Řezníčková E,Heger T,Gucký T,Řezáčová P,Lyčka A,Kryštof V.  (2021)  Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure.,  216  [PMID:33711765] [10.1016/j.ejmech.2021.113309]

Source